Patient P-01654
Synthetic patientNBL-101 · Day 116 · 35–44 · M · baseline S08Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
4%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S08
- Day 63 CR-01 recommended — Clinician Review CR-01
- Day 64 Patient accepted — Started CR-01 in the companion
- Day 69 Deterioration detected before clinical escalation — Clinician Review CR-01
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity-9
- GI instability-5
- Inflammatory activity-5
- Nutritional resilience+2
- Treatment adherence+2
What helped?
- Clinician Review CR-01Day 63Result: deterioration detected before clinical escalation
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion11.9/100
improving · -7.4 vs previous 14 d
Toxicity
Blood6.5/100
improving · -6.7 vs previous 14 d
Sleep quality
Wearable23.6/100
improving · +3.5 vs previous 14 d
Energy level
Daily log7.4/10
improving · +0.6 vs previous 14 d
Stress level
Daily log4.6/10
improving · -0.6 vs previous 14 d
Steps
Wearable3,095
improving · +406 vs previous 14 d
Adherence
Companion95.4 %
stable · -0.6 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 98 from the failing basin, 11 from restoration.
Good elements to keep
- Clinician Review CR-01intervention · steering +14.4
- Butyrate producers intacthidden · steering +7.5
Main detractors to watch
- FUT2 non-secretorhidden · steering -10.6
- Low microbial diversityhidden · steering -7.7
- Bacteroides fragilis elevatedhidden · steering -7.4
- Antibiotic courseperturbation · steering -4.7
- Simple carbohydratesdetractor · GI +2.4 next day
- Histamine loaddetractor · GI +2.3 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates+2.4detractor · 95%
- Histamine load+2.3detractor · 95%
- Dietary fat load+1.1no signal · 33%
- Spicy / capsaicin+1no signal · 35%
- Insoluble fibre+0.6no signal · 18%
- Alcohol-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓65
- WearableResting HR 74 bpm
- Wearable3,095 steps/day
- WearableShort sleep window
- Mucosal barrier integrity ↓40
- DNAFUT2 non-secretor lowers mucosal fucosylation
- WearableSleep 5.6 h, below personal baseline
- Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 34 ms, trending down
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.9 · butyrate capacity 70/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 37 ms
- Sleep
- 6.2 h
- Steps
- 4,260
- Resting HR
- 73 bpm
Daily log: GI score 12, nutritional resilience 65, adherence 95.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.